Rollins Inc.
ROL
$38.56
-2.23%
Rollins, Inc. is a global leader in route-based pest control services, operating primarily through its flagship Orkin brand in the United States and across multiple continents. As the dominant player in the North American pest control market, Rollins distinguishes itself through its extensive route network, strong brand recognition, and recurring residential and commercial service contracts. The current investor narrative centers on the company's ability to sustain mid-single-digit organic revenue growth amid a challenging macroeconomic environment, while also navigating margin pressures from labor and fuel costs. Recent attention has focused on Rollins' consistent free cash flow generation and its potential for continued market share gains in a fragmented industry.…
ROL
Rollins Inc.
$38.56
Investment Opinion: Should I buy ROL Today?
Rating: Hold. Rollins is a high-quality business with consistent revenue growth and strong cash flows, but the stock's elevated valuation and negative momentum warrant caution. The analyst consensus is Buy with an average target of $45.59, implying 18.2% upside, but the recent price action suggests the market is pricing in significant risks.
Supporting Evidence: Revenue grew 10.2% YoY in Q1 2026, accelerating from 8.3% in Q4 2025. The forward P/E of 29.4x is above the industry average of 22x, but the company's gross margin of 50.8% exceeds the industry average of ~40%. Free cash flow of $621.1 million TTM provides a yield of 2.1%. ROE of 38.3% is exceptional. However, the PEG ratio of 4.1x indicates the stock is expensive relative to its expected earnings growth rate of ~7% (implied by the gap between trailing and forward P/E).
Risks & Conditions: The Hold rating could upgrade to Buy if the stock pulls back to the $32-35 range (near the analyst low target) or if operating margins show a clear recovery toward 20% in the next two quarters. A downgrade to Sell would be warranted if revenue growth decelerates below 8% or if margins continue to compress, leading to earnings misses. Overall, Rollins appears overvalued relative to its historical P/E range of 35-65x, trading near the upper end at 55.1x trailing. The stock is not a compelling value at current levels, but it is not a sell given the business quality and analyst support.
Sign up to view all
ROL 12-Month Price Forecast
Rollins is a high-quality business facing near-term margin headwinds and a stock that has been severely de-rated. The base case of stabilization and modest upside to the analyst target is most likely, but the risk of further downside to the low target is real. The neutral stance reflects the balanced risk/reward: the stock is not cheap enough to be a clear buy, but the business fundamentals are strong enough to avoid a sell. Upgrading to bullish would require evidence of margin recovery, while a bearish shift would follow continued deterioration in margins or growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rollins Inc.'s 12-month outlook, with a consensus price target around $45.59 and implied upside of +18.2% versus the current price.
Average Target
$45.59
0 analysts
Implied Upside
+18.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$32 - $66
Analyst target range
Rollins is covered by 17 analysts, with a consensus recommendation of 'Buy' and an average target price of $45.59. Based on the current price of $38.56, this implies an upside potential of approximately 18.2%. The distribution shows a bullish tilt, with the mean recommendation score of 2.26 (where 1 is Strong Buy and 5 is Strong Sell) indicating a generally positive outlook. However, recent rating actions show caution: Bernstein downgraded from Outperform to Market Perform in May 2026, while Wells Fargo maintained Equal Weight. The target price range spans from a low of $32.00 to a high of $66.00, representing a wide spread of 106% from low to high. The high target of $66.00 assumes a return to the 52-week high, likely predicated on a successful turnaround in organic growth and margin expansion. The low target of $32.00 implies further downside of 17% and reflects risks such as continued margin compression, competitive pressures, or a recession impacting demand. The wide range signals high uncertainty among analysts about the company's near-term trajectory. The recent downgrade by Bernstein and the absence of upgrades suggest that sentiment is cautiously optimistic but not exuberant.
Drowning in data?
Find the real signal!
Bulls vs Bears: ROL Investment Factors
Rollins presents a classic tension between a high-quality business with consistent revenue growth, strong cash flows, and impressive ROE, and a stock that has been severely punished by the market, trading at a premium valuation that leaves little room for error. The bull case hinges on the company's ability to stabilize margins and deliver on earnings growth expectations, which would justify the forward P/E of 29.4x. The bear case centers on margin compression, elevated valuation, and negative technical momentum that could persist if growth disappoints. Currently, the bearish evidence from price action and margin trends appears stronger, but the analyst consensus Buy and 18% upside potential suggest the sell-off may be overdone. The single most important factor to watch is whether operating margins can recover toward 20% in the coming quarters.
Bullish
- Consistent Revenue Growth: Rollins delivered Q1 2026 revenue of $906.4 million, up 10.2% year-over-year, accelerating from 8.3% in Q4 2025. This demonstrates resilient demand in a mature industry, supported by pricing power and market share gains.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $621.1 million, providing a free cash flow yield of ~2.1%. This cash generation supports dividends (payout ratio 62.3%) and strategic acquisitions.
- High Return on Equity: ROE stands at 38.3%, reflecting efficient capital allocation and high profitability. This is well above the industry average, indicating Rollins' ability to generate shareholder value.
- Analyst Consensus Buy with Upside: 17 analysts rate the stock a Buy with an average target of $45.59, implying 18.2% upside from the current price of $38.56. The high target of $66 suggests significant potential if conditions improve.
Bearish
- Elevated Valuation Multiples: Trailing P/E of 55.1x and forward P/E of 29.4x are well above the industry average of ~22x. The PEG ratio of 4.1x indicates the stock is expensive relative to expected growth, leaving little room for error.
- Margin Compression Trend: Operating margin fell from 21.9% in Q3 2025 to 16.1% in Q1 2026, driven by higher SG&A expenses. Net margin also declined from 15.9% to 11.9% over the same period, signaling cost pressures.
- Severe Price Decline and Momentum: The stock is down 33.6% over the past year and 13.4% in the last month alone, trading just 5.4% above its 52-week low. This persistent downtrend reflects negative sentiment and selling pressure.
- High Short Interest Risk: Short ratio of 2.81 indicates elevated bearish positioning. While this could fuel a short squeeze, it also signals that many investors expect further downside.
ROL Technical Analysis
Rollins is in a pronounced downtrend, with the stock declining 33.6% over the past year and currently trading at $38.56, just 5.4% above its 52-week low of $36.59 and 41.7% below its 52-week high of $66.14. This positioning near the bottom of the range suggests persistent selling pressure and a lack of buying conviction, indicating the stock is in a bear market phase. The 1-year price change of -33.6% starkly contrasts with the S&P 500's +16.5% gain, highlighting severe relative underperformance. Short-term momentum remains decisively negative, with the stock losing 13.4% over the past month and 31.9% over the past three months. The 1-month decline of -13.4% is accelerating from the 3-month decline, signaling that selling pressure is intensifying rather than abating. This divergence from the broader market, which gained 0.8% in the past month, underscores Rollins' acute weakness and suggests a potential capitulation phase. The 52-week low of $36.59 serves as critical support; a breakdown below this level could trigger further downside toward the $32 low analyst target. Resistance sits at the 52-week high of $66.14, but more immediate resistance is near the $45 area, where the stock traded in early July. With a beta of 0.75, Rollins is less volatile than the market, meaning its 33.6% decline reflects company-specific issues rather than broad market turbulence. The high short ratio of 2.81 indicates elevated bearish sentiment, which could fuel a short squeeze if positive catalysts emerge.
Beta
0.75
0.75x market volatility
Max Drawdown
-41.2%
Largest decline past year
52-Week Range
$37-$66
Price range past year
Annual Return
-33.6%
Cumulative gain past year
| Period | ROL Return | S&P 500 |
|---|---|---|
| 1m | -13.4% | +1.4% |
| 3m | -31.9% | +3.3% |
| 6m | -38.7% | +6.3% |
| 1y | -33.6% | +16.0% |
| ytd | -34.7% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ROL Fundamental Analysis
Rollins reported Q1 2026 revenue of $906.4 million, representing 10.2% year-over-year growth, accelerating from the 8.3% growth in Q4 2025 and 9.9% in Q1 2025. The revenue trajectory remains solidly positive, driven by both organic growth and acquisitions, with residential contract revenue of $389.5 million and commercial contract revenue of $311.7 million forming the core. However, the growth rate has decelerated from the 11.5% pace seen in Q3 2025, suggesting a modest slowdown. The company's ability to consistently grow revenue above 8% in a mature industry underscores its market leadership and pricing power. Profitability is robust, with Q1 2026 net income of $107.8 million and a net margin of 11.9%, though this is down from 15.9% in Q3 2025. Gross margin of 50.8% in Q1 2026 is relatively stable, but operating margin compressed to 16.1% from 21.9% in Q3 2025, reflecting higher selling, general, and administrative expenses. The trailing twelve-month free cash flow of $621.1 million is strong, representing a free cash flow yield of approximately 2.1% based on the current market cap. The balance sheet is moderately leveraged with a debt-to-equity ratio of 0.76 and a current ratio of 0.60, indicating some liquidity tightness. However, the company generates ample operating cash flow ($118.4 million in Q1 2026) to cover capital expenditures and dividends, with a payout ratio of 62.3%. Return on equity is an impressive 38.3%, reflecting efficient capital allocation and high profitability.
Quarterly Revenue
$906424000.0B
2026-03
Revenue YoY Growth
+10.2%
YoY Comparison
Gross Margin
50.8%
Latest Quarter
Free Cash Flow
$621138000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ROL Overvalued?
Since Rollins has positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 55.1x, while the forward P/E is 29.4x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward P/E suggests that analysts anticipate a sharp recovery in earnings, likely driven by margin expansion or revenue acceleration. Compared to the specialty business services industry average P/E of approximately 22x, Rollins trades at a 150% premium on a trailing basis and a 34% premium on a forward basis. This premium is partially justified by Rollins' superior gross margin of 50.8% versus the industry average of around 40%, and its consistent revenue growth. However, the PEG ratio of 4.1x indicates that the stock is expensive relative to its expected earnings growth rate, suggesting limited upside if growth disappoints. Historically, Rollins' trailing P/E has ranged from 35x to 65x over the past five years. The current 55.1x is near the upper end of that range, indicating that the market is pricing in optimistic expectations for future growth. If the company fails to deliver on those expectations, the stock could de-rate significantly.
PE
55.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 36x~66x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
35.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Rollins' balance sheet shows a debt-to-equity ratio of 0.76 and a current ratio of 0.60, indicating some liquidity tightness. While operating cash flow of $118.4 million in Q1 2026 covers interest and dividends, the low current ratio could become problematic if revenue growth slows. The net margin has declined from 15.9% in Q3 2025 to 11.9% in Q1 2026, and operating margin fell from 21.9% to 16.1% over the same period, driven by rising SG&A costs. If this margin compression continues, earnings could fall short of the $1.67 consensus EPS estimate, putting further pressure on the stock. The high payout ratio of 62.3% limits dividend growth potential and financial flexibility.
Market & Competitive Risks: The stock's trailing P/E of 55.1x is a 150% premium to the industry average of 22x, making it vulnerable to multiple compression if growth decelerates. With a beta of 0.75, Rollins is less correlated to the market, but its 33.6% decline versus the S&P 500's 16.5% gain highlights company-specific weakness. The pest control industry is fragmented, and competitive pressures could intensify, especially from regional players offering lower prices. Recent analyst actions, including a downgrade from Bernstein to Market Perform, reflect growing caution. Regulatory risks around pesticide usage or labor laws could also impact costs.
Worst-Case Scenario: If margin compression persists and revenue growth decelerates below 8%, earnings could miss estimates, leading to further analyst downgrades and multiple compression. The stock could fall to the analyst low target of $32.00, representing a 17% decline from the current price of $38.56. This would be a 52% drop from the 52-week high of $66.14. In a severe recession scenario, demand for pest control services could weaken, and the stock might test its 52-week low of $36.59 or lower, resulting in a potential loss of up to 17% for investors buying at current levels.
FAQ
The key risks include: 1) Margin compression—operating margin fell from 21.9% in Q3 2025 to 16.1% in Q1 2026, and if this trend continues, earnings could miss estimates. 2) Valuation risk—the trailing P/E of 55.1x leaves little room for error; a de-rating to 40x would imply a 27% downside. 3) Competitive pressure—the pest control industry is fragmented, and larger competitors or regional players could undercut pricing. 4) Macro sensitivity—while beta is low at 0.75, a recession could reduce demand for residential and commercial pest control services. The most severe risk is a combination of margin compression and growth deceleration, which could drive the stock to the analyst low target of $32.
The 12-month forecast is mixed. In the base case (50% probability), the stock trades in the $38-45 range, aligning with the analyst average target of $45.59. In the bull case (25% probability), margin recovery and growth acceleration could push the stock to $45-55. In the bear case (25% probability), continued margin compression and growth deceleration could drive the stock to $32-38, testing the 52-week low of $36.59. The most likely scenario is the base case, assuming the company stabilizes margins and meets consensus EPS of $1.67. Investors should monitor the next earnings report for signs of margin improvement.
Rollins appears overvalued relative to its history and peers. The trailing P/E of 55.1x is near the high end of its 5-year range of 35-65x, and it trades at a 150% premium to the specialty business services industry average of 22x. The forward P/E of 29.4x is more reasonable but still above the industry average. The PEG ratio of 4.1x indicates the stock is expensive relative to its expected earnings growth. The market is pricing in optimistic expectations for margin recovery and continued growth. If the company delivers on those expectations, the valuation could be justified, but any disappointment could lead to significant multiple compression.
Rollins is a high-quality business with consistent revenue growth (10.2% YoY in Q1 2026) and strong free cash flow ($621.1 million TTM), but the stock is not a clear buy at current levels. The trailing P/E of 55.1x is expensive relative to the industry average of 22x, and the PEG ratio of 4.1x suggests limited upside if growth disappoints. However, the analyst consensus is Buy with an average target of $45.59, implying 18.2% upside. For long-term investors willing to hold through volatility, the stock could be a good buy if it pulls back to the $32-35 range. Short-term traders should be cautious given the negative momentum and high short interest of 2.81 days to cover.
Rollins is better suited for long-term investment given its business quality, consistent growth, and cash flow generation. The stock has a beta of 0.75, indicating lower volatility than the market, but its recent 33.6% decline shows it can experience significant drawdowns. The dividend yield of 1.13% and payout ratio of 62.3% provide some income, but the yield is modest. Short-term trading is risky due to negative momentum and high short interest (2.81 days to cover). A minimum holding period of 3-5 years is recommended to allow the company to work through margin pressures and for the stock to re-rate. Long-term investors can benefit from the company's market leadership and recurring revenue model.
